Minimization of immunosuppressive therapy after renal transplantation: Results of a randomized controlled trial

Y Vanrenterghem, JP van Hooff, JP Squifflet, K Salmela, P Rigotti, RM Jindal, J Pascual, Henrik Ekberg, LS Sicilia, JN Boletis, JM Grinyo, MA Rodriguez

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

    106 Citeringar (SciVal)

    Sammanfattning

    Modern immunosuppressive regimens reduce the acute rejection rate by combining a cornerstone immunosuppressant like tacrolimus or cyclosporine with adjunctive agents like corticosteroids, mycophenolate mofetil (MMF) or azathioprine, often associated with untoward side effects. A 6-month randomized study was conducted in 47 European centers. Triple therapy with tacrolimus (trough levels 5-15 ng/mL), corticosteroids (dosage 10 mg/day) and MMF (1 g/day) was administered for 3 months. From day 92, patients either continued with triple therapy (control, n = 277), or stopped steroids (n = 279), or stopped MMF (n = 277). Surrogate markers for long-term benefits were changes in lipid profiles and occurrence of hematological, gastrointestinal and infectious complications. The 6-month acute rejection incidence (biopsy-proven) was similar in all groups (17.0% vs. 15.1% vs. 14.8%, p = 0.744), although the incidence after month 3 was higher in the steroid stop group than in the two other groups. Mean reductions in total cholesterol (18.9 mg/dL [0.49 mmol/L]) and LDL-cholesterol (8.1 mg/dL [0.21 mmol/L]) between months 4 and 6 were greater in the steroid stop group (p < 0.001). Leukopenia (p = 0.0082), serious CMV infection (p = 0.024), anemia (p = NS) and diarrhea (p = NS) were less frequent in the MMF stop group. In a study population of immunologically low-risk patients' withdrawal of corticosteroids or MMF from a tacrolimus-based therapy at 3 months was feasible. A longer follow-up will be needed to confirm the expected advantages for the long-term outcome and to assess the long-term safety of this minimization of immunosuppressive therapy.
    Originalspråkengelska
    Sidor (från-till)87-95
    TidskriftAmerican Journal of Transplantation
    Volym5
    Utgåva1
    DOI
    StatusPublished - 2005

    Ämnesklassifikation (UKÄ)

    • Kirurgi

    Fingeravtryck

    Utforska forskningsämnen för ”Minimization of immunosuppressive therapy after renal transplantation: Results of a randomized controlled trial”. Tillsammans bildar de ett unikt fingeravtryck.

    Citera det här